Speaker Profile

M.D., Ph.D., Genomics Co-Founder, Inocras

Biography
He completed his post-doctoral research at Cancer Genome Project, Wellcome Sanger Institute (England) and published more than 80 original articles, including Nature (2023, 2021), Cell (2009), Cell Genomics (2024), Journal of Clinical Oncology (2017), and Annals of Oncology (2017). He also identified KIF5B-RET fusion oncogene in lung cancer. With the goal of revolutionizing how genomic data is used in healthcare, he innovates Inocrass genome technologies to pave the way for truly personalized precision medicine.


Talk
Inocras: Real-World Clinical Utility of Cancer Whole Genome Dx
Inocras will introduce CancerVision, its flagship target-enhanced whole genome cancer profiling Dx product, and real world insights from 1,300+ breast cancer whole genome data. This presentation will demonstrate the power of cancer whole genome Dx in the clinical and research settings.


Clinical Dx Showcase:
Inocras Inc.

Inocras is an AI-driven whole genome sequencing and bioinformatics company that specializes in cancer and rare disease. The company offers its whole genome testing products, CancerVision, MRDVision and RareVision, and provides research services for pharmaceutical, biotechnology companies and research organizations through its CAP/CLIA lab.

 Session Abstract – PMWC 2025 Silicon Valley

Showcase Track S2 - February 5 11.00 A.M.-4.45 P.M.,Showcase Track S2 - February 6 9.15 A.M.-4.45 P.M.,Showcase Track S2 - February 7 11.00 A.M.-1.30 P.M.


The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by APR. 24TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required